Blepharitis

• FDA approval · 2025-04-07
  FDA Approved: TOBRAMYCIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)

  Supplemental FDA approval for tobramycin and dexamethasone (Sandoz) as an ophthalmic combination product.

• FDA approval · 2023-07-24
  FDA Approved: XDEMVY — Original Application (Tarsus Pharmaceuticals, Inc.)

  FDA approved XDEMVY (lotilaner ophthalmic solution) from Tarsus Pharmaceuticals for the treatment of Demodex blepharitis.

• FDA approval · 2019-04-19
  FDA Approved: TOBRAMYCIN OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approved Tobramycin Ophthalmic Solution from Alembic Pharmaceuticals Inc. under an original generic application (ANDA).

• FDA approval · 2017-12-18
  FDA Approved: MAXITROL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for MAXITROL (neomycin sulfate, polymyxin B sulfate and dexamethasone) from Novartis Pharmaceuticals…

• FDA approval · 2013-03-12
  FDA Approved: AZASITE — Supplemental Application (Thea Pharma Inc.)

  The FDA approved a supplemental application for AZASITE (azithromycin monohydrate ophthalmic solution) submitted by Thea Pharma Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-02-13
  FDA Approved: TOBRADEX ST — Original Application (Harrow Eye, LLC)

  The FDA approved TOBRADEX ST (tobramycin/dexamethasone) from Harrow Eye, LLC via an original NDA for treating ocular infections and inflamma…

• FDA approval · 2008-09-15
  FDA Approved: NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Sandoz Inc.)

  FDA approved a supplemental application for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (Sandoz) to support a generic version of thi…